Home
Categories
EXPLORE
True Crime
Comedy
Business
Society & Culture
Sports
News
Health & Fitness
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/df/70/72/df7072b1-5f4b-9698-843c-df648a86cfdb/mza_15271150116437396241.jpg/600x600bb.jpg
IMPACT Medicom
IMPACT Medicom
55 episodes
5 days ago
In this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap. Our guest Dr. Puckrin is a Hematologist and Clinician Investigator at the Arthur Child Comprehensive Cancer Centre and Alberta Blood and Marrow Transplant Program. He is also a clinical assistant professor at the University of Calgary. Dr Puckrin has received honoraria for advisory boards and/or speaking engage...
Show more...
Science
RSS
All content for IMPACT Medicom is the property of IMPACT Medicom and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap. Our guest Dr. Puckrin is a Hematologist and Clinician Investigator at the Arthur Child Comprehensive Cancer Centre and Alberta Blood and Marrow Transplant Program. He is also a clinical assistant professor at the University of Calgary. Dr Puckrin has received honoraria for advisory boards and/or speaking engage...
Show more...
Science
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/df/70/72/df7072b1-5f4b-9698-843c-df648a86cfdb/mza_15271150116437396241.jpg/600x600bb.jpg
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
IMPACT Medicom
16 minutes
1 year ago
LIVE FROM EHA 2024 - Sonrotoclax plus Zanubrutinib in R/R CLL
In this episode of our podcast, recorded at the European Hematology Association (EHA) meeting in Madrid, Spain, we discuss updated results of the BGB-11417-101 trial with Dr. Stephen Opat. The BGB-11417-101 trial examined the efficacy and safety of sonrotoclax plus zanubrutinib for the treatment of R/R CLL. Our Guest: Dr. Stephen Opat is the director of Clinical Haematology at Monash Health, founder and chair of the Australasian Lymphoma and Related Diseases Registry and lead inve...
IMPACT Medicom
In this episode with Dr Robert Puckrin, we discuss the unmet needs of double-exposed patients with CLL/SLL, as well as the current and novel treatments that can address this gap. Our guest Dr. Puckrin is a Hematologist and Clinician Investigator at the Arthur Child Comprehensive Cancer Centre and Alberta Blood and Marrow Transplant Program. He is also a clinical assistant professor at the University of Calgary. Dr Puckrin has received honoraria for advisory boards and/or speaking engage...